These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. [Bromocriptine in Parkinson's disease: pleuropulmonary toxicity]. Douvier JJ; Vergeret J; Taytard A; Brottier E; Domblides P; Dubos F; Freour P Ann Med Interne (Paris); 1985; 136(5):416-8. PubMed ID: 4062141 [TBL] [Abstract][Full Text] [Related]
8. [Pleural effusion and constrictive pericarditis secondary to bromocriptine treatment]. Saura J; Aguilar M; Alió J Neurologia; 1991 Nov; 6(9):331-3. PubMed ID: 1809340 [TBL] [Abstract][Full Text] [Related]
9. [Pleuropneumopathy caused by bromocriptine in a patient with Parkinson disease. Review of the literature apropos of a new case]. Debove P; Simon F; Vaylet F; Renard JL; L'Her P Ann Med Interne (Paris); 1998 Apr; 149(3):167-71. PubMed ID: 11490541 [TBL] [Abstract][Full Text] [Related]
10. [Pleural effusion induced by bromocriptine]. Diot E; Diot P; Le Rolland A; Jonville AP; Lasfargues G; Lemarie E; Lavandier M; Guilmot JL Rev Mal Respir; 1990; 7(2):175-7. PubMed ID: 2320790 [TBL] [Abstract][Full Text] [Related]
11. Pleuropulmonary changes during treatment of Parkinson's disease with a long-acting ergot derivative, cabergoline. Frans E; Dom R; Demedts M Eur Respir J; 1992 Feb; 5(2):263-5. PubMed ID: 1348483 [TBL] [Abstract][Full Text] [Related]
12. [Combined treatment of the early stages of Parkinson's syndrome with bromocriptine and levodopa. The results of a multicenter study]. Fischer PA; Przuntek H; Majer M; Welzel D Dtsch Med Wochenschr; 1984 Aug; 109(34):1279-83. PubMed ID: 6381019 [TBL] [Abstract][Full Text] [Related]
13. [Pleuropulmonary fibrosis and bromocriptine]. Vergeret J; Barat M; Taytard A; Bellvert P; Domblides P; Douvier JJ; Fréour P Sem Hop; 1984 Mar; 60(11):741-4. PubMed ID: 6324351 [TBL] [Abstract][Full Text] [Related]
14. [Pergolide-induced pleural effusion in a patient with juvenile parkinsonism]. Kuwabara T Rinsho Shinkeigaku; 2002 Aug; 42(8):757-60. PubMed ID: 12701223 [TBL] [Abstract][Full Text] [Related]
15. Pleural disease during treatment with bromocriptine in patients previously exposed to asbestos. Hillerdal G; Lee J; Blomkvist A; Rask-Andersen A; Uddenfeldt M; Koyi H; Rasmussen E Eur Respir J; 1997 Dec; 10(12):2711-5. PubMed ID: 9493648 [TBL] [Abstract][Full Text] [Related]
16. [Pleural effusion and severe edema of the lower limbs induced by bromocriptine]. Messiaen T; Lefebvre C; Weynand B; Pieters T Rev Med Interne; 1996; 17(8):680-3. PubMed ID: 8881198 [TBL] [Abstract][Full Text] [Related]
17. Pleural effusion during bromocriptine exposure in two patients with pre-existing asbestos pleural plaques: a relationship? Knoop C; Mairesse M; Lenclud C; Gevenois PA; De Vuyst P Eur Respir J; 1997 Dec; 10(12):2898-901. PubMed ID: 9493681 [TBL] [Abstract][Full Text] [Related]
18. [Pleuro-pulmonary changes after bromocriptine treatment of parkinsonism]. Bøttcher J; Grøn U Ugeskr Laeger; 1981 Oct; 143(41):2648-9. PubMed ID: 7303288 [No Abstract] [Full Text] [Related]
19. Hypersexuality--a complication of dopaminergic therapy in Parkinson's disease. Vogel HP; Schiffter R Pharmacopsychiatria; 1983 Jul; 16(4):107-10. PubMed ID: 6685318 [TBL] [Abstract][Full Text] [Related]